You are leaving Evergreentgn.com
You have clicked on an external link and will be taken offsite.
Cancel
Confirm
Lantheus has completed its acquisition of Evergreen Theragnostics, Inc. Please see the
press release
to learn more.
CDMO
Pipeline
Therapeutic Areas
Menu
About us
Facilities
News
Careers
CDMO
Pipeline
Therapeutic Areas
About us
Facilities
News
Careers
menu
Close
News
view details
September 30, 2021
Clarity and Evergreen enter Targeted Copper Theranostics manufacturing agreement for US clinical trials
view details
August 16, 2021
Cellectar Announces Manufacturing and Supply Agreement with Evergreen Theragnostics for CLR-131, now known as iopofosine I-131
view details
July 14, 2021
Evergreen Theragnostics Expands Alpha Radiopharmaceutical Production Capabilities
view details
April 28, 2021
Precirix partners with Evergreen to expand North American clinical trial supply
view details
September 23, 2020
Evergreen Theragnostics Begins Construction of New Manufacturing Facility
1
...